FDA-Inspected Site

Opella Healthcare International SAS

5 FDA inspections are on record for Opella Healthcare International SAS in Compiegne, France.

Clean· No action indicated

Compiegne, France · Last updated July 9, 2026

Overview

  • 5 FDA inspections are on record.
  • 3 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-01-10.

At a glance

Inspections

5

Form 483s

3

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
6 Jan 2025 – 10 Jan 2025Human DrugsClean
28 Oct 2019 – 31 Oct 2019Human DrugsClean
19 Jun 2017 – 23 Jun 2017Human Drugs483View 483 →
14 Sep 2015 – 18 Sep 2015Human Drugs483View 483 →
13 Sep 2013 – 19 Sep 2013Human Drugs483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

23 Jun 2017
21 CFR 211.113(a)

Procedures for non-sterile drug products

Cited by Satheesh Thomas

23 Jun 2017
21 CFR 211.194(a)(4)

Complete Test Data

Cited by Satheesh Thomas

23 Jun 2017
21 CFR 211.25(a)

Training , Education , Experience overall

Cited by Satheesh Thomas

23 Jun 2017
21 CFR 211.63

Equipment Design, Size and Location

Cited by Satheesh Thomas

18 Sep 2015
21 CFR 211.160(a)

Following/documenting laboratory controls

Cited by Samina S Khan, Charanjeet Jassal

Investigators

FDA investigators tied to this site in the record.

MRA M BarbosaR1 insp.
MRA McCulloughJ1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.160(a)Cited across public-safe Form 483 observations2x
21 CFR 211.192Cited across public-safe Form 483 observations2x
21 CFR 211.113(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.170(b)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.198(a)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.46(b)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Opella Healthcare International SAS' 3 Form 483s

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat